Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  BB BIOTECH AG    BION   CH0038389992

BB BIOTECH AG (BION)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
08/08/2018 08/09/2018 08/10/2018 08/13/2018 08/14/2018 Date
68.2(c) 67.85(c) 67.7(c) 67.1(c) 66.9 Last
40 686 31 953 42 016 59 287 43 085 Volume
+0.15% -0.51% -0.22% -0.89% -0.30% Change
More quotes
Financials (CHF)
Sales 2018 -
EBIT 2018 617 M
Net income 2018 619 M
Debt 2018 208 M
Yield 2018 4,78%
Sales 2019 -
EBIT 2019 429 M
Net income 2019 273 M
Debt 2019 341 M
Yield 2019 5,00%
P/E ratio 2018 8,30
P/E ratio 2019 13,25
EV / Sales2018 0
EV / Sales2019 0
Capitalization 3 743 M
More Financials
Company
BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies.It focuses on companies whose products address areas of significant unmet medical needs and generates above-average sales and profit growth.The company was founded on November 9, 1993 and is... 
Sector
Biotechnology & Medical Research
Calendar
10/19 | 07:00amEarnings Release
More about the company
Surperformance© ratings of BB BIOTECH AG
Trading Rating : - Investor Rating :
More Ratings
Latest news on BB BIOTECH AG
07/31BB BIOTECH : holds steady in the second quarter
AQ
07/20BB BIOTECH : shares hold steady in the second quarter
EQ
07/12BB BIOTECH : reports preliminary results for 1H 2018
EQ
07/09BB BIOTECH : admitted to the SMIM and SPI Index
EQ
04/23BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
04/23BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
04/20BB BIOTECH : share gains value in first quarter 2018 - several large-cap biotech..
EQ
03/15BB BIOTECH AG : Ex-dividend day for final dividend
FA
03/13BB BIOTECH AG : Shareholders at the general meeting vote in favor of all proposa..
EQ
02/16BB BIOTECH : publishes its 2017 annual report
EQ
More news
Sector news : Biotechnology & Medical Research - NEC
08/03Roche Drug for Brain Disease Granted European Fast-Track
DJ
08/02Regeneron Closes Up 7% After 2Q Earnings Beat -- Data Talk
DJ
08/02REGENERON PHARMACEUTICALS : Beats Earnings Estimates
DJ
07/31UNITED THERAPEUTICS : Medtronic Get FDA OK for Remodulin Implantable System
DJ
07/27JOHNSON & JOHNSON : J&J's Janssen Gets Positive CHMP Opinion for Darzalex as Fro..
DJ
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
07/25$BIO #Bb Biotech BB BIOTECH - Index inclusions, numerous portfolio adjustment.. 
07/20BB Biotech shares hold steady in the second quarter (news with additional fe.. 
07/12BB Biotech AG reports preliminary results for 1H 2018  
07/09BB Biotech AG admitted to the SMIM and SPI Index  
07/06The Medicines Company $MDCO CEO Clive Meanwell Sells 50,000 Shares of Stock  
More tweets
Qtime:40
News from SeekingAlpha
2016Myovant Sciences IPO Attracts Major Pharma Interest 
2015WINNERS CIRCLE 2014 TOP HEDGE FUND M : Healthcare Funds, Nine Of Top Ten Spots 
Chart BB BIOTECH AG
Duration : Period :
BB BIOTECH AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BB BIOTECH AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 73,3  CHF
Spread / Average Target 9,3%
EPS Revisions
Managers
NameTitle
Erich Hunziker Chairman
Clive A. Meanwell Vice Chairman
Klaus Strein Director
Claude Mikkelsen Director-Investor Relations
Felicia Flanigan Senior Biotech Analyst
Sector and Competitors
1st jan.Capitalization (M$)
BB BIOTECH AG3.95%3 763
CELLTRION, INC.--.--%28 909
IQVIA HOLDINGS INC23.75%24 543
LONZA GROUP21.15%23 934
INCYTE CORPORATION-31.96%13 698
SEATTLE GENETICS, INC.37.94%11 644